deltatrials
Completed OBSERVATIONAL NCT02045407

Computed Tomography Angiography Accuracy in Brain Death Diagnosis

Sponsor: Sergio Brasil, MD MSc

Conditions Brain Death
Updated 9 times since 2017 Last updated: Jul 18, 2019 Started: Jan 31, 2014 Primary completion: Jan 31, 2018 Completion: Jan 31, 2019
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A observational or N/A phase clinical study on Brain Death, this trial is completed. The trial is conducted by Sergio Brasil, MD MSc and has accumulated 9 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Study Description(click to expand)

Critically ill patients, presenting Glasgow Coma Score 5 or lower, will be submitted to the Computed Tomography Angiography (CTA) of the skull assessment, and follow a clinical evaluation for brain death, additionally, transcranial Doppler would be applied as the gold standard for brain death. We will exclude patients whose do not can be submitted to contrast injection, or if a brain death clinical evaluation has been performed prior the CTA.

Critically ill patients, presenting Glasgow Coma Score 5 or lower, will be submitted to the Computed Tomography Angiography (CTA) of the skull assessment, and follow a clinical evaluation for brain death, additionally, transcranial Doppler would be applied as the gold standard for brain death.

We will exclude patients whose do not can be submitted to contrast injection, or if a brain death clinical evaluation has been performed prior the CTA.

Status Flow

~Jan 2017 – ~Feb 2017 · 31 days · monthly snapshotRecruiting~Feb 2017 – ~Apr 2018 · 14 months · monthly snapshotCompleted~Apr 2018 – ~Jun 2018 · 2 months · monthly snapshotCompleted~Jun 2018 – ~Apr 2019 · 10 months · monthly snapshotCompleted~Apr 2019 – ~Aug 2019 · 4 months · monthly snapshotCompleted~Aug 2019 – ~Jan 2021 · 17 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 19 months · monthly snapshotCompleted

Change History

9 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed

  2. Jul 2024 — Sep 2024 [monthly]

    Completed

  3. Jan 2021 — Jul 2024 [monthly]

    Completed

  4. Aug 2019 — Jan 2021 [monthly]

    Completed

  5. Apr 2019 — Aug 2019 [monthly]

    Completed

Show 4 earlier versions
  1. Jun 2018 — Apr 2019 [monthly]

    Completed

  2. Apr 2018 — Jun 2018 [monthly]

    Completed

    Phase: NANone

  3. Feb 2017 — Apr 2018 [monthly]

    Completed NA

    Status: RecruitingCompleted

  4. Jan 2017 — Feb 2017 [monthly]

    Recruiting NA

    First recorded

Jan 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Sergio Brasil, MD MSc
  • University of Sao Paulo
Data source: University of Sao Paulo

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations